Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception-Reference-Cited by-同舟云学术

Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception

Published:2002-12 Issue:6 Volume:78 Page:1154-1158
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Mathur Raj,Hayman Grant,Bansal Amolak,Jenkins Julian

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference20 articles.

1. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion;Semba;Pathol Int,2000

2. Distinction between early and late ovarian hyperstimulation syndrome;Mathur;Fertil Steril,2000

3. The pathophysiology of ovarian hyperstimulation syndrome—views and ideas;Elchalal;Hum Reprod,1997

4. Increased capillary permeability induced by human follicular fluid;Goldsman;Fertil Steril,1995

5. Amato P, Zwain I, Yen SSC. Identification of vascular endothelial growth factor in human follicular fluid: a possible role in ovarian hyperstimulation syndrome. Proceedings of the 52nd Annual Meeting of the American Society of Reproductive Medicine; Birmingham, Alabama. Boston:1996

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of ovarian hyperstimulation syndrome;Fertility Science and Research;2022

2. Correlation Between Vascular Endothelial Growth Factor (VEGF) and Ovarian Hyperstimulation Syndrome (OHSS); A Retrospective Study.;SunKrist Journal of Obstetrics and Gynecology Research;2020-06-25

3. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation;Journal of Assisted Reproduction and Genetics;2018-09-19

4. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial;Journal of Assisted Reproduction and Genetics;2017-08-03

5. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study;Fertility and Sterility;2016-09